<!DOCTYPE html>
<html lang="en">
<head>
	<meta charset="UTF-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title>ISOBM</title>
	<script src="bower_components/jquery/dist/jquery.min.js"></script>
	<script src="bower_components/bootstrap/dist/js/bootstrap.min.js"></script>
	<link rel="stylesheet" href="bower_components/bootstrap/dist/css/bootstrap.min.css">
	<link rel="stylesheet" href="bower_components/font-awesome/css/font-awesome.min.css">
	<link rel="stylesheet" href="css/style.css">
</head>
<body>
	<header>
		<!-- Btn menu Mobile -->
		<div class="btn-menu"><i class="fa fa-bars" aria-hidden="true"></i> menu</div>
		<!-- Menu -->
		<nav class="menu">
			<ul class="list-unstyled">
				<a href="#"><li>Home</li></a>
				<a href="#"><li>Congress</li></a>
				<a href="#"><li>Programmee</li></a>
				<a href="#"><li>Gallery</li></a>
				<a href="#"><li>News</li></a>
				<a href="#"><li>Registration Forms</li></a>
				<a href="#"><li>Contact us</li></a>
			</ul>
		</nav>
		<!-- Cebeçalho -->
		<div class="container-fluid cabecalho">
			<div class="row">
				<div class="pelicula"></div>
				<!-- Conteúdo Cabeçalho -->
				<div class="content-header">
					<div class="container">
						<div class="row logo-total">
							<div class="col-lg-offset-1 col-lg-4 col-md-offset-1 col-md-4 col-sm-offset-0 col-sm-4 col-xs-offset-4 col-xs-4 logo">
								<img src="img/isobm_logo.png" alt="">
							</div>
							<div class="col-lg-6 col-md-6 col-sm-8 col-xs-12">
								<div class="row">
									<div class="text-logo-normal col-lg-12 col-md-12">
										<p>International Society of Oncology and Biomarkers Sociedade Internacional de Oncologia e Biomarcadores</p>
									</div>
								</div>
								<div class="row">
									<div class="col-lg-12 col-md-12 col-sm-12 text-total">
										<h1 class="text-logo-big">44º congresso anual da isobm</h1>
									</div>
								</div>
							</div>
						</div>
						<div class="row mobile">
							<div class="col-lg-12 col-md-12 col-xs-12">
								<p>International Society of Oncology and Biomarkers Sociedade Internacional de Oncologia e Biomarcadores</p>
							</div>
						</div>
						<div class="row info">
							<div class="col-lg-4 col-md-4 col-xs-12 bloco-data">
								<p>7 a 10 de setembro de 2017</p>
								<h3>rio de janeiro, brasil</h3>
							</div>
							<div class="col-lg-4 col-md-4 col-xs-12 bloco-local">
								<h3>Rio Othon Palace</h3>
							</div>
							<div class="col-lg-4 col-md-4 col-xs-12 btn-inscreva-se">
								<h2>INSCREVA-SE AQUI</h2>
							</div>
						</div>
						<div class="row">
							<div class="col-lg-12 saiba-mais">
								<p><a href="#doctor">saiba mais <i class="fa fa-angle-double-down" aria-hidden="true"></i></a></p>
							</div>
						</div>
					</div>
				</div>
			</div>
		</div>
	</header>
	<main>
		<div class="container total-content">
			<div class="row">
				<div id="doctor" class="doctor col-xs-12 col-lg-3">
					<div class="img-doc"></div>
					<p>Dr. Adagmar Andriolo  <br> Presidente do 44º congresso anual da ISOBM <br> Rio de Janeiro, RJ, Brasil</p>
				</div>
				<div class="text-topics col-xs-12 col-lg-9">
					<!-- <p class="topic-title">Preliminary Scientific Program</p> -->
					<div class="topics">
						<p>Dear colleagues,</p>
						<p>On behalf of the International Society of Oncology and Biomarkers, I am pleased to invite you to participate actively in the 44th ISOBM Congress, to be held in Rio de Janeiro, Brazil, from September 7 to 10, 2017.</p>
						<p>With the theme "Biomarkers in oncology: new horizons and challenges in the diagnosis and treatment of cancer", the Congress will bring together different fields of basic research in oncology and daily practice in the care of cancer patients. With the aim of bringing new findings to clinical practice, this Congress will be a great opportunity to improve the clinical results of cancer patients through the rational use of biomarkers. Participants will have the opportunity to exchange ideas and expertise in an international forum, meet with professionals and colleagues from around the world, and attend lectures delivered by prominent leaders in the fields of Cancer Research, Oncology, and Biomarkers.
						The presence of a wide range of commercial exhibitors, showing all their products and services directed to oncology, adds an additional value to the event, enabling a profitable exchange between different suppliers and users.</p>

						<p>In addition to the stimulating scientific program of the Congress, participants will have the opportunity to enjoy the Marvelous City, as the city of Rio de Janeiro is known worldwide. Corcovado Mountain and Christ the Redeemer Statue, Morro da Urca, Copacabana, Ipanema, Leblon beaches, Museo of Tomorrow, are just some of the many social and cultural attractions that Rio will offer us.
						You will surely have a good time!</p>
						 
						<p>I look forward to meeting you at this unique event.</p>


<!-- 					<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;News in clinical guidelines of EGTM – European Group on Tumor Markers.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Algorithms in cancer diagnosis – prostatic, lung, unknown primary cancer.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Serum markers for Cutaneous and Uveal Melanoma – new guidelines.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;pplications of tumor markers – screening, early diagnosis of recurrence.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Validation of Cancer Biomarkers – from discover to the clinical use.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Update on tumor markers in hormone-dependent tumors.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;New tumor markers – HE-4, PIVKA, ProGRP, DNA circulating.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;HE-4 in endometrial carcinoma.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Update on prostate cancer markers – PSA, PCA3, p2PSA.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Standardization of tumor markers in ovarian cancer – CA 125 and HE-4: ROMA index.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;New nucleic acid-based markers in human diseases.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Genetic of cancer – clinical applications in diagnosis and therapy.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Circulating cancer cells – utility in cancer evaluation.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Plasma tumor DNA – from concept to clinical application. </p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Plasma tumor DNA – clinical applications in cancer research.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Epigenetics – from knowledge to clinical applications.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Cancer proteomics and epigenetics – new applications.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Development of epigenetic biomarkers in urological cancer detection.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Screening of colorectal cancer.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Screening of lung cancer.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;New therapies in lung cancer – genetics and biomarkers in personalization of lung therapy.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Immunotherapy for management of cancer patients.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Anticancer drugs and new therapeutic strategies.</p>
						<p><i class="fa fa-angle-double-right" aria-hidden="true"></i>&ensp;Cancer and inflammation.</p> -->
					</div>
				</div>
			</div>
			<!-- <div class="parceiros col-lg-7">
				<div class="row">
					<div class="col-lg-4 col-xs-4 partners"></div>
					<div class="col-lg-4 col-xs-4 partners"></div>
					<div class="col-lg-4 col-xs-4 partners"></div>
				</div>
				<div class="row">
					<div class="col-lg-4 col-xs-4 partners"></div>
					<div class="col-lg-4 col-xs-4 partners"></div>
					<div class="col-lg-4 col-xs-4 partners"></div>
				</div>
				<div class="row">
					<div class="col-lg-6 col-xs-6 partners"></div>
					<div class="col-lg-6 col-xs-6 partners"></div>
				</div>
			</div> -->
			<div class="video col-md-12">
			<p>Conheça o rio de janeiro</p>
			<iframe width="100%" height="500" src="https://www.youtube.com/embed/6cYIaMk9mr8" frameborder="0" allowfullscreen></iframe></div>
			<div class="sbpc col-lg-offset-3 col-lg-6 col-md-offset-3 col-md-6 col-sm-offset-3 col-sm-6 col-xs-offset-3 col-xs-6">
				<img src="img/logo.png" alt="">
			</div>
		</div>
	</main>

	<footer>
		<div class="pelicula"></div>
		<div class="total-footer">
			<div class="txt-footer"><p>© 2017 - 44º congresso anual da isobm | desenvolvido por</p></div>
			<div class="credit-campana"><img src="img/agencia-campana_logo.png" alt=""></div>
		</div>
	</footer>

	<script>
	// Script Menu Mobile
	   $('.btn-menu').on('click touchstart', function(e){
        $('html').toggleClass('menu-active');
        e.preventDefault();
    })
	</script>
</body>
</html>